26 June 2025 : Clinical Research
Six-Year Outcomes of CABG vs PCI in Diabetic Patients with Multivessel Coronary Disease
Szymon JonikDOI: 10.12659/MSM.948348
Med Sci Monit 2025; 31:e948348
Table 4 Primary and secondary endpoints.
| Endpoints | Overall (317) | CABG (98) | PCI (219) | P value |
|---|---|---|---|---|
| All-cause death, n (%) | 61 (19.2) | 16 (16.3) | 45 (20.5) | 0.38 |
| MACCE, n (%) | 227 (71.6) | 44 (44.9) | 183 (83.6) | <0.01 |
| MI, n (%) | 31 (9.8) | 4 (4.1) | 27 (12.3) | 0.02 |
| Stroke, n (%) | 21 (6.6) | 8 (8.2) | 13 (5.9) | 0.46 |
| Repeat revascularization, n (%) | 120 (37.9) | 17 (17.3) | 103 (47.0) | <0.01 |
| In-hospital mortality, n (%) | 3 (0.9) | 2 (2.0) | 1 (0.5) | 0.18 |
| Postprocedural hospital stay, days; mean (SD) | 6.5 (1.2) | 10.7 (1.9) | 4.4 (0.8) | <0.01 |
| CABG – coronary artery bypass grafting; MACCE – major adverse cardiac and cerebrovascular events; MI – myocardial infarction; PCI – percutaneous coronary intervention. | ||||






